Release Date: 01/12/17 18:40 Summary: Further Results of 2017 Drill Program Price Sensitive: Yes Download Document 2.84MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%